Thyroid hormone receptor beta is essential for development of auditory function

被引:288
作者
Forrest, D
Erway, LC
Ng, L
Altschuler, R
Curran, T
机构
[1] UNIV CINCINNATI, DEPT BIOL SCI, CINCINNATI, OH 45221 USA
[2] UNIV MICHIGAN, KRESGE HEARING RES INST, ANN ARBOR, MI 48109 USA
[3] ST JUDE CHILDRENS RES HOSP, DEPT DEV NEUROBIOL, MEMPHIS, TN 38105 USA
关键词
D O I
10.1038/ng0796-354
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Congenital thyroid disorders are often associated with profound deafness, indicating a requirement for thyroid hormone (T3) and its receptors in the development of hearing. Two T3 receptor genes, Trα and Trβ, are differentially expressed, although in overlapping patterns, during development. Thus, the extent to which they mediate unique or redundant functions is unclear. We demonstrate that Trβ-deficient (Thrb(-/-)) mice exhibit a permanent deficit in auditory function across a wide range of frequencies, although they show no other overt neurological defects. The auditory-evoked brainstem response (ABR) in Thrb(-/-) mice, although greatly diminished, displayed normal waveforms, which suggested that the primary defect resides in the cochlea. Although hypothyroidism causes cochlear malformation, there was no evidence of this in Thrb(-/-) mice. These findings suggest that Trβ controls the maturation of auditory function but not morphogenesis of the cochlea. Thrb(-/-) mice provide a model for the human endocrine disorder of resistance to thyroid hormone (RTH), which is typically associated with dominant mutations in Trβ. However, deafness is generally absent in RTH, indicating that dominant and recessive mutations in Trβ have different consequences on the auditory system. Our results identify Trβ as an essential transcription factor for auditory development and indicate that distinct Tr genes serve certain unique functions.
引用
收藏
页码:354 / 357
页数:4
相关论文
共 34 条
  • [1] AUDITORY INVESTIGATIONS IN HYPOTHYROIDISM
    ANAND, VT
    MANN, SBS
    DASH, RJ
    MEHRA, YN
    [J]. ACTA OTO-LARYNGOLOGICA, 1989, 108 (1-2) : 83 - 87
  • [2] ALPHA-THYROID AND BETA-THYROID HORMONE-RECEPTOR (TR) GENE-EXPRESSION DURING AUDITORY NEUROGENESIS - EVIDENCE FOR TR ISOFORM-SPECIFIC TRANSCRIPTIONAL REGULATION IN-VIVO
    BRADLEY, DJ
    TOWLE, HC
    YOUNG, WS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 439 - 443
  • [3] GENETIC AND CLINICAL-FEATURES OF 42 KINDREDS WITH RESISTANCE TO THYROID-HORMONE - THE NATIONAL-INSTITUTES-OF-HEALTH PROSPECTIVE-STUDY
    BRUCKERDAVIS, F
    SKARULIS, MC
    GRACE, MB
    BENICHOU, J
    HAUSER, P
    WIGGS, E
    WEINTRAUB, BD
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) : 572 - 583
  • [4] BURROW GN, 1994, NEW ENGL J MED, V331, P1072
  • [5] A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS
    CHEN, JD
    EVANS, RM
    [J]. NATURE, 1995, 377 (6548) : 454 - 457
  • [6] TRANSCRIPTION FACTORS INNER-EAR DEVELOPMENT
    COREY, DP
    BREAKEFIELD, XO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 433 - 436
  • [7] PROTEIN ENCODED BY V-ERBA FUNCTIONS AS A THYROID-HORMONE RECEPTOR ANTAGONIST
    DAMM, K
    THOMPSON, CC
    EVANS, RM
    [J]. NATURE, 1989, 339 (6226) : 593 - 597
  • [8] DEESCOBAR GM, 1991, ADV EXP MED BIOL, V299, P133
  • [9] Delong G. Robeert, 1993, American Journal of Clinical Nutrition, V57, p286S, DOI 10.1093/ajcn/57.2.286S
  • [10] DEOL MS, 1976, ACTA OTO-LARYNGOL, V81, P429